These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27376555)

  • 1. Cyclopamine disrupts tumor extracellular matrix and improves the distribution and efficacy of nanotherapeutics in pancreatic cancer.
    Zhang B; Jiang T; Shen S; She X; Tuo Y; Hu Y; Pang Z; Jiang X
    Biomaterials; 2016 Oct; 103():12-21. PubMed ID: 27376555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclopamine treatment disrupts extracellular matrix and alleviates solid stress to improve nanomedicine delivery for pancreatic cancer.
    Zhang B; Wang H; Jiang T; Jin K; Luo Z; Shi W; Mei H; Wang H; Hu Y; Pang Z; Jiang X
    J Drug Target; 2018 Dec; 26(10):913-919. PubMed ID: 29533111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoradiation therapy using cyclopamine-loaded liquid-lipid nanoparticles and lutetium-177-labeled core-crosslinked polymeric micelles.
    You J; Zhao J; Wen X; Wu C; Huang Q; Guan F; Wu R; Liang D; Li C
    J Control Release; 2015 Mar; 202():40-8. PubMed ID: 25637565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclopamine increases the cytotoxic effects of paclitaxel and radiation but not cisplatin and gemcitabine in Hedgehog expressing pancreatic cancer cells.
    Shafaee Z; Schmidt H; Du W; Posner M; Weichselbaum R
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):765-70. PubMed ID: 16552573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers.
    Feldmann G; Dhara S; Fendrich V; Bedja D; Beaty R; Mullendore M; Karikari C; Alvarez H; Iacobuzio-Donahue C; Jimeno A; Gabrielson KL; Matsui W; Maitra A
    Cancer Res; 2007 Mar; 67(5):2187-96. PubMed ID: 17332349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomimetic nanoparticles delivered hedgehog pathway inhibitor to modify tumour microenvironment and improved chemotherapy for pancreatic carcinoma.
    Jiang T; Zhang B; Zhang L; Wu X; Li H; Shen S; Luo Z; Liu X; Hu Y; Pang Z; Jiang X
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):1088-1101. PubMed ID: 29484905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micellar delivery of cyclopamine and gefitinib for treating pancreatic cancer.
    Chitkara D; Singh S; Kumar V; Danquah M; Behrman SW; Kumar N; Mahato RI
    Mol Pharm; 2012 Aug; 9(8):2350-7. PubMed ID: 22780906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celecoxib normalizes the tumor microenvironment and enhances small nanotherapeutics delivery to A549 tumors in nude mice.
    Zhang B; Jin K; Jiang T; Wang L; Shen S; Luo Z; Tuo Y; Liu X; Hu Y; Pang Z
    Sci Rep; 2017 Aug; 7(1):10071. PubMed ID: 28855534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor Microenvironment Modulation by Cyclopamine Improved Photothermal Therapy of Biomimetic Gold Nanorods for Pancreatic Ductal Adenocarcinomas.
    Jiang T; Zhang B; Shen S; Tuo Y; Luo Z; Hu Y; Pang Z; Jiang X
    ACS Appl Mater Interfaces; 2017 Sep; 9(37):31497-31508. PubMed ID: 28849917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging monitors physiological changes with antihedgehog therapy in pancreatic adenocarcinoma xenograft model.
    Guimaraes AR; Rakhlin E; Weissleder R; Thayer SP
    Pancreas; 2008 Nov; 37(4):440-4. PubMed ID: 18953259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy of paclitaxel and cyclopamine polymer-drug conjugates to treat advanced prostate cancer.
    Yang R; Mondal G; Wen D; Mahato RI
    Nanomedicine; 2017 Feb; 13(2):391-401. PubMed ID: 27520724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of sonic hedgehog signal pathway enhances antiproliferative effect of EGFR inhibitor in pancreatic cancer cells.
    Hu WG; Liu T; Xiong JX; Wang CY
    Acta Pharmacol Sin; 2007 Aug; 28(8):1224-30. PubMed ID: 17640486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis.
    Thayer SP; di Magliano MP; Heiser PW; Nielsen CM; Roberts DJ; Lauwers GY; Qi YP; Gysin S; Fernández-del Castillo C; Yajnik V; Antoniu B; McMahon M; Warshaw AL; Hebrok M
    Nature; 2003 Oct; 425(6960):851-6. PubMed ID: 14520413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sonic-hedgehog pathway inhibition normalizes desmoplastic tumor microenvironment to improve chemo- and nanotherapy.
    Mpekris F; Papageorgis P; Polydorou C; Voutouri C; Kalli M; Pirentis AP; Stylianopoulos T
    J Control Release; 2017 Sep; 261():105-112. PubMed ID: 28662901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination paclitaxel and inhibitor of nuclear factor κB activation improves therapeutic outcome for model mice with peritoneal dissemination of pancreatic cancer.
    Fujiwara Y; Furukawa K; Shimada Y; Iida T; Shiba H; Uwagawa T; Misawa T; Ohashi T; Yanaga K
    Pancreas; 2011 May; 40(4):600-7. PubMed ID: 21343836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors.
    Wang J; Lu Z; Wang J; Cui M; Yeung BZ; Cole DJ; Wientjes MG; Au JL
    J Control Release; 2015 Oct; 216():103-10. PubMed ID: 26272765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix control of pancreatic cancer: New insights into fibronectin signaling.
    Topalovski M; Brekken RA
    Cancer Lett; 2016 Oct; 381(1):252-8. PubMed ID: 26742464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of hedgehog signaling depresses self-renewal of pancreatic cancer stem cells and reverses chemoresistance.
    Huang FT; Zhuan-Sun YX; Zhuang YY; Wei SL; Tang J; Chen WB; Zhang SN
    Int J Oncol; 2012 Nov; 41(5):1707-14. PubMed ID: 22923052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer therapy.
    Zhao J; Wang H; Hsiao CH; Chow DS; Koay EJ; Kang Y; Wen X; Huang Q; Ma Y; Bankson JA; Ullrich SE; Overwijk W; Maitra A; Piwnica-Worms D; Fleming JB; Li C
    Biomaterials; 2018 Mar; 159():215-228. PubMed ID: 29331808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and biological evaluation of paclitaxel loaded biodegradable PCL/PEG nanoparticles for the treatment of human neuroendocrine pancreatic tumor in mice.
    Dubey N; Shukla J; Hazari PP; Varshney R; Ganeshpurkar A; Mishra AK; Trivedi P; Bandopadhaya GP
    Hell J Nucl Med; 2012; 15(1):9-15. PubMed ID: 22413106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.